Product Description
Emgrast M 500Mcg Injection is an immunostimulator, a GM-CSF (recombinant granulocyte macrophage colony stimulating factor) that is prescribed to cancer patients for fighting infections. It is helps accelerate the recovery of white blood cells after chemotherapy and is prescribed to patients after chemotherapy in Acute Myelogenous Leukemia (AML), bone marrow transplantation, and peripheral blood stem cell transplantation.
How is Emgrast M Injection administered?Emgrast M Injection can be given either subcutaneously or intravenously by a healthcare professional. The specific route and dosage depend on the patient's medical condition and the intended use, such as chemotherapy-induced neutropenia or PBPC mobilization. Always follow your physician's instructions for safe administration.
What are the benefits of using Emgrast M Injection?The primary benefit of Emgrast M Injection is its ability to increase white blood cell counts, which helps prevent infections in patients with neutropenia due to chemotherapy, radiotherapy, or bone marrow transplantation. It also aids in the mobilization of progenitor cells for transplantation purposes, facilitating quicker recovery and improving overall treatment outcomes.
What should I know about storage and disposal?Emgrast M Injection should be stored in a refrigerator at 2C to 8C and must not be frozen. Always check the batch number and expiry date on the pack before use. Dispose of any unused product or waste material according to local regulations for pharmaceutical products to ensure environmental safety.
FAQ's of Emgrast M Injection:
Q: How should Emgrast M Injection be administered?
A: Emgrast M Injection is administered by a healthcare provider through subcutaneous or intravenous injection. The appropriate route and dose will be determined by your physician based on your clinical condition and therapeutic requirements.
Q: What conditions does Emgrast M Injection treat?
A: Emgrast M Injection is prescribed for neutropenia caused by chemotherapy or radiotherapy, provides support during bone marrow transplantation, and assists in mobilizing peripheral blood progenitor cells for collection and transplantation procedures.
Q: When should Emgrast M Injection be used during treatment?
A: The injection is typically used during or after chemotherapy, radiotherapy, or bone marrow transplantation when a drop in white blood cell count is anticipated or identified. Your doctor will define the precise timing and dosage regimen.
Q: Where can I find the batch number and expiry date of Emgrast M Injection?
A: The batch number and expiry date are clearly mentioned on each Emgrast M Injection pack, ensuring traceability and safety during administration.
Q: What's the process for manufacturing Emgrast M Injection?
A: Emgrast M Injection is produced by recombinant DNA technology in Escherichia coli. After the fermentation process at 30-37C, the product is purified, formulated as an isotonic solution, and filled into sterile glass vials or prefilled syringes.
Q: How do I properly dispose of unused Emgrast M Injection?
A: Unused product or waste material must be disposed of according to local regulatory guidelines. Do not dispose of in household waste; consult your healthcare provider or pharmacist for specific disposal instructions.
Q: What makes Emgrast M Injection a safe choice for patients?
A: Emgrast M Injection is manufactured in compliance with Pharmacopeia standards, ensuring sterility, safety, and therapeutic consistency. Each batch meets strict quality specifications, and the solution is clear, colorless to slightly yellow, with no odor.